GLP-1 and GLP-1 receptor agonists are effective in treating a number of long-term conditions, such as diabetes, thanks to the Nrf2 signaling pathway’s antioxidative mechanisms [47]. This evidence concerns the gene GLP1R and diabetes mellitus.